[Form 4] REPLIGEN CORP Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Repligen Corporation director reported several transactions in company stock. On 11/13/2025, the director sold multiple blocks of common stock in open-market transactions at weighted average prices ranging from $151.01 to $157.11, each sale covering different share amounts. After these sales, the director beneficially owned 80,743 shares of Repligen common stock in direct form. The director also exercised a stock option for 2,952 shares at an exercise price of $33.87, which increased directly held shares while reducing the option position.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 20,000 shares ($3,092,278)
Net Sell
9 txns
Insider
Hunt Anthony
Role
Director
Sold
20,000 shs ($3.09M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 2,952 | $0.00 | -- |
| Sale | Common Stock | 1,784 | $151.01 | $269K |
| Sale | Common Stock | 2,100 | $152.17 | $320K |
| Sale | Common Stock | 2,923 | $153.14 | $448K |
| Sale | Common Stock | 2,500 | $154.32 | $386K |
| Sale | Common Stock | 3,000 | $155.45 | $466K |
| Sale | Common Stock | 5,737 | $156.22 | $896K |
| Sale | Common Stock | 1,956 | $157.11 | $307K |
| Exercise | Common Stock | 2,952 | $33.87 | $100K |
Holdings After Transaction:
Stock Option (Right to Buy) — 14,760 shares (Direct);
Common Stock — 98,959 shares (Direct)
Footnotes (1)
- $151.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.53 to $151.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $152.17 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.57 to $152.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $153.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.64 to $153.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $154.32 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.66 to $154.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $155.45 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.78 to $155.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $156.22 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.79 to $156.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $157.11 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.90 to $157.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. 14,760 of the shares underlying this option have vested. The remaining shares vest as follows: 2,952 shares on March 1, 2026, and 2,952 shares on March 1, 2027.